Adherium (ADR) Stock Price, News & Analysis

Company Overview

Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around patient inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal, as well as Hailie remote patient management solution. The company was founded in 2001 and is based in Melbourne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 38,277 shs
• Average Volume: N/A
• Market Capitalization: A$9.10 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ASX:ADR
• CIK: N/A
• Web: www.adherium.com
• Phone: 64 9 307 2771
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$10.22 million
• Net Margins: -1,215.74%
• Pretax Margin: N/A
• Return on Equity: -184.15%
• Return on Assets: -57.95%

Debt

• Debt-to-Equity Ratio: 1.44
• Current Ratio: 2.90
• Quick Ratio: 2.31

Sales & Book Value

• Annual Sales: A$2.35 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 10.00
• Book Value: A$0.02 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 333,440,000
• Free Float: N/A
• Market Cap: A$9.10 million
• Optionable: Not Optionable
• Beta: 2.40